logo
  

Gordmans Stores Q2 Loss Narrows; Issues Q3 Outlook - Quick Facts

Gordmans Stores, Inc. (GMAN), an Omaha-based apparel and home décor retailer, posted second-quarter net loss of $3.0 million, narrower than $3.2 million in the comparable quarter last year. Loss per share was $0.16, same as last year.

Net loss for the 2015 second quarter, as adjusted to exclude the debt extinguishment charge, narrowed to $1.8 million, or $0.09 per share from $3.2 million or $0.16 per share, in the second quarter of fiscal 2014. On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.14 per share. Analysts' estimates typically exclude special items.

Net sales for the latest second quarter rose by 1.7% to $143.43 million from $141.04 million in the prior year, while three analysts had a consensus revenue estimate of $145.45 million for the quarter.

Looking ahead to the third quarter, the company expects loss per share in the range of $0.15 to $0.12 and net sales to be between $153 million and $156 million. Analysts currently expect third quarter earnings of $0.10 per share on revenues of $155.79 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT